Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

17.65
BATS BZX Real-Time Price
As of 10:08am ET
 -0.05 / -0.28%
Today’s Change
9.88
Today|||52-Week Range
19.90
+17.28%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close17.70
Today’s open17.80
Day’s range17.58 - 17.80
Volume10,758
Average volume (3 months)868,504
Market cap$1.3B
Dividend yield--
Data as of 10:08am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-365.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book3.38

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc+0.11+0.37%
FPRXFive Prime Therapeut...+0.27+0.88%
EPZMEpizyme Inc+0.20+1.40%
CHRSCoherus BioSciences ...-0.20-1.30%
Data as of 10:10am ET, 06/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Scott M. Storer
Corporate headquarters
Cambridge, Massachusetts

Forecasts